MAP3K3 and melanoma: To test whether MAP3K3 knockdown can suppress the malignant behavior of vemurafenib-resistant melanoma cells, we examined the cell proliferation and migration ability abilities in vitro and the tumor formation capacity in xenografted immunocompromised mice.